Skip to main content
Line Kemeyou
( out of 18 reviews )

Line Kemeyou, MD

Languages spoken: Italian, English, French

Clinical Locations

University of Utah Hospital

Heart Transplant Clinic
Salt Lake City
801-585-5122

University of Utah Hospital

Heart Failure Clinic
Salt Lake City
801-585-5122

University of Utah Hospital

Salt Lake City
801-585-5122
  • Dr. Line Kemeyou received her medical degree from the University of Texas Southwestern Medical School (UTSW) in Dallas. She then completed her training in Internal Medicine and in Cardiovascular Diseases at the University of Texas Southwestern Medical School (UTSW) and the University of Florida, respectively. She continued her training with an Advanced Heart Failure and Transplantation Fellowship at the University of Utah.

    Dr. Kemeyou is board certified in General Cardiology and Advanced Heart Failure and Transplant. Her clinical interests include improvement in health care delivery, cardiac sarcoidosis, and care of patients with severe congestive heart failure including the use of mechanical circulatory support devices and cardiac transplantation.

    Dr. Kemeyou will be seeing patients at the Cardiovascular Center at the University Hospital and at the George E. Wahlen VA Medical Center. To refer patients and other related inquiries, or to schedule clinic appointments please call 801-585-5122.

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
    American Board of Internal Medicine (Sub: Cardiovascular Disease)

    Patient Rating

    4.9 /5
    ( out of 18 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    April 04, 2024
    UH HOSPITALS AND CLINICS

    Dr. Kemeyou is thorough, honest,highly qualified , and makes her patients feel comfortable and important!

    April 01, 2024
    UH HOSPITALS AND CLINICS

    It was a pleasure to be seen by her. She was a great listener and had a very nice ¿bedside manner. Asked me a lot of good questions. Clearly has the knowledge and passion for what she is doing. Very impressed.

    February 12, 2024
    UH HOSPITALS AND CLINICS

    Dr. Line Kemeyou is outstanding!

    January 24, 2024
    UH HOSPITALS AND CLINICS

    Dr. Line Kemeyou is very, very thorough in getting to know you, your history and your life activities in order to attain a better direction for your care. She explained multiple options and which one would be best suited for my situation. Meeting her and her team has educated me in the reality of what¿s involved in moving forward with a transplant.

    January 18, 2024
    UH HOSPITALS AND CLINICS

    Dr Kemeyou is an excellent phenomenal physician with great knowledge and a great bed side manor

    December 16, 2023
    UH HOSPITALS AND CLINICS

    Line Kemeyou MD was very personable, respectful, knowledgeable, she made you feel comfortable and explained things so I could understand them! Very good MD, THANK YOU!!

    October 15, 2023
    UH HOSPITALS AND CLINICS

    Very nice to work with, Dr. Kemeyou inspires confidence that I'm in good hands!

    July 16, 2023
    UH HOSPITALS AND CLINICS

    Very caring and concerned about my health

    July 08, 2023
    UH HOSPITALS AND CLINICS

    She is very good and very easy to talk to. I could tell thar she was as frustrated as I was because she did not have the test results. She also said she would have ordered a stress test done also.

  • Dr. Line Kemeyou received her medical degree from the University of Texas Southwestern Medical School (UTSW) in Dallas. She then completed her training in Internal Medicine and in Cardiovascular Diseases at the University of Texas Southwestern Medical School (UTSW) and the University of Florida, respectively. She continued her training with an Advanced Heart Failure and Transplantation Fellowship at the University of Utah.

    Dr. Kemeyou is board certified in General Cardiology and Advanced Heart Failure and Transplant. Her clinical interests include improvement in health care delivery, cardiac sarcoidosis, and care of patients with severe congestive heart failure including the use of mechanical circulatory support devices and cardiac transplantation.

    Dr. Kemeyou will be seeing patients at the Cardiovascular Center at the University Hospital and at the George E. Wahlen VA Medical Center. To refer patients and other related inquiries, or to schedule clinic appointments please call 801-585-5122.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Cardiovascular Medicine
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
    American Board of Internal Medicine (Sub: Cardiovascular Disease)

    Education history

    Fellowship Advanced Heart Failure & Transplant - University of Utah School of Medicine Fellow
    Cardiovascular Disease - University of Florida College of Medicine Fellow
    Residency Internal Medicine - Parkland Health & Hospital System Resident
    Internal Medicine - Parkland Health & Hospital System Intern
    Professional Medical Medicine - University of Texas Southwestern Medical School M.D.
    Nursing - University of Texas Health Science Center at Houston BSN

    Selected Publications

    Journal Article

    1. Nguyen QT, Cabal V, Debbink M, Acosta D, Flattes VJ, Baluchi D, Ovuoba N, Cariello PF, Watts BT, Clouse ER, Nyman H, Taylor E, Kemeyou L, Lucero JE, Washington JC, Figueroa E, Campbell KM, Barbaar A, Ogbeide SA, Rodrguez JE (2024). Building an Equity-Centered Ecosystem: University of Utah Health as a Microcosm. J Racial Ethn Health Disparities. (Read full article)
    2. Noroozi Gilandehi S, Wong KH, Francis T, Wright MA, Lord J, Stehlik J, Kemeyou L, Smith T, Clardy SL (2024). Cardiac Involvement in Neurosarcoidosis: A Single-Center Investigation. Neurol Neuroimmunol Neuroinflamm, 11(2), e200196. (Read full article)
    3. Chamberlin JH, Kocher MR, Aquino G, Fullenkamp A, Dennis DJ, Waltz J, Stringer N, Wortham A, Varga-Szemes A, Rieter WJ, James WE, Houston BA, Hardie AD, Kabakus I, Baruah D, Kemeyou L, Burt JR (2023). Quantitative myocardial T2 mapping adds value to Japanese circulation society diagnostic criteria for active cardiac sarcoidosis. Int J Cardiovasc Imaging, 39(8), 1535-1546. (Read full article)
    4. Battistone MJ, Kemeyou L, Varpio L (2023). The Theoretical Integrative Review-A Reader's Guide. J Grad Med Educ, 15(4), 449-452. (Read full article)
    5. Battistone MJ, Kemeyou L, Varpio L (2023). The Theoretical Integrative Review-A Researcher's Guide. J Grad Med Educ, 15(4), 453-455. (Read full article)
    6. Stoesser K, Frame KA, Sanyer O, Leiser JP, Moreno LE, Bosch C, Jones JL, Morales JJ, Rodrguez SR, Wilson J, Kemeyou L, Rodrguez JE (2021). Increasing URiM Family Medicine Residents at University of Utah Health. PRiMER, 5, 42. (Read full article)
    7. Money JE, Al Danaf J, Nelson M, Mckellar SH, Drakos SG, Kemeyou L (2020). Loss of Pulsatility: Another Cause of Syncope in Patients with Left Ventricular Assist Devices. ASAIO J. (Read full article)
    8. Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik J (2019). Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant, 38(8), 858-869. (Read full article)

    Case Report

    1. Money JE, Al Danaf J, Nelson M, Mckellar SH, Drakos SG, Kemeyou L (2020). Loss of Pulsatility: Another Cause of Syncope in Patients with Left Ventricular Assist Devices. ASAIO J, 66(10), e128-e130. (Read full article)

    Editorial

    1. Hanff TC, Kemeyou L (2021). Impaired Forced Expiratory Volume Across the Heart Failure Spectrum. Chest, 161(1), 11-12. (Read full article)
    2. Josef Stehlik, Line Kemeyou (2019). Protecting the Heart Allograft with a Statin: The Perfect Intervention or Too Good to Be True?

    Other

    1. Marashly Q, Taleb I, Kyriakopoulos CP, Dranow E, Jones TL, Tandar A, Overton SD, Tonna JE, Stoddard K, Wever-Pinzon O, Kemeyou L, Koliopoulou AG, Shah KS, Nourian K, Richins TJ, Burnham TS, Welt FG, McKellar SH, Nativi-Nicolau J, Drakos SG (2021). Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score. Catheter Cardiovasc Interv (98(7), pp. 1275-1284). United States. (Read full article)
    2. Wohlfahrt P, Nativi-Nicolau J, Zhang M, Selzman CH, Greene T, Conte J, Biber JE, Hess R, Mondesir FL, Wever-Pinzon O, Drakos SG, Gilbert EM, Kemeyou L, LaSalle B, Steinberg BA, Shah RU, Fang JC, Spertus JA, Stehlik J (2022). Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction. JAMA Cardiol (6(8), pp. 957-962). United States. (Read full article)
  • News & Podcasts